NCT07847294 The Effectiveness of an Occupation-Based Lifestyle Program in Individuals With Type 2 Diabetes
| NCT ID | NCT07847294 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Medipol University |
| Condition | Diabete Type 2 |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2026-09-01 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the effect of an occupation-focused lifestyle program on occupational performance, self-management, occupational balance, diabetes symptoms, and quality of life in individuals with Type 2 diabetes. Type 2 diabetes requires continuous daily management, yet conventional interventions often show limited long-term behavioral sustainability. Occupation-focused lifestyle interventions offer a holistic approach by addressing daily routines, self-management skills, and personal goals. In this non-invasive, quasi-experimental study, participants aged 18-74 with Type 2 diabetes will be invited via social media announcements. Participants will be divided into an intervention group and a control group. The intervention group will receive an online, 5-module (8 sessions) Occupation-Focused Lifestyle Program via Zoom, covering diabetes awareness, problem-solving, stress management (mindfulness), energy conservation/physical activity, and goal review. The control group will receive an informative brochure after the intervention group completes the program. Outcomes will be measured online before and after the program using structured scales to evaluate changes in daily functioning, self-care, and overall well-being
Eligibility Criteria
Inclusion Criteria: * Diagnosed with Type 2 Diabetes Mellitus for at least 12 months * Aged between 18 and 74 years * Ability to provide documented proof of Type 2 diabetes diagnosis (e.g., medical report or official documentation) * Having access to a smartphone, tablet, or computer with an internet connection to attend online Zoom sessions and complete online questionnaires -Voluntary agreement to participate in the study and submission of an online informed consent form Exclusion Criteria: * Presence of severe diabetic complications that significantly impair independent daily function (e.g., severe proliferative retinopathy, end-stage renal disease, active foot ulcers, or severe diabetic neuropathy) * Cognitive impairment, acute psychiatric conditions, or sensory deficits (uncorrected visual or hearing impairments) that impede active participation in group sessions or online communication * Participation in another structured diabetes self-management program or lifestyle intervention trial simultaneously
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07847294 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 74 Years, studying Diabete Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07847294 currently recruiting?
Yes, NCT07847294 is actively recruiting participants. Contact the research team at sena.albay@ankaramedipol.edu.tr for enrollment information.
Where is the NCT07847294 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07847294 clinical trial?
NCT07847294 is sponsored by Ankara Medipol University. The trial plans to enroll 42 participants.